UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
|
|||
FORM
10-Q
|
|||
þ QUARTERLY REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
|||
For
the quarterly period ended January 31, 2010
OR
TRANSITION REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF
1934
For
the transition period from ___________ to ___________
Commission
File Number 1-5865
|
|||
Gerber
Scientific, Inc.
(Exact
name of registrant as specified in its charter)
|
|||
Connecticut
|
06-0640743
|
||
(State
or other jurisdiction of incorporation or organization)
|
(I.R.S.
Employer Identification No.)
|
||
83
Gerber Road West, South Windsor, Connecticut
(Address
of principal executive offices)
|
06074
(Zip
Code)
|
||
Registrant's
telephone number, including area code: (860)
644-1551
|
|||
Indicate
by check mark whether the registrant (1) has filed all reports required to
be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days. Yes þ No
|
|||
Indicate
by check mark whether the registrant has submitted electronically and
posted on its corporate Web site, if any, every Interactive Data File
required to be submitted and posted pursuant to Rule 405 of Regulation S-T
(§232.405 of this chapter) during the preceding 12 months (or for such
shorter period that the registrant was required to submit and post such
files). Yes No
|
|||
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting
company. See the definitions of “large accelerated filer,”
“accelerated filer” and “smaller reporting company” in Rule 12b-2 of the
Exchange Act.
Large
accelerated filer
Accelerated
filer þ
Non-accelerated
filer (Do not check if a smaller reporting
company) Smaller reporting
company
|
|||
Indicate
by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act).
Yes
No þ
|
|||
25,157,590
shares of common stock of the registrant were outstanding as of February
28, 2010, exclusive of treasury shares.
|
|||
GERBER
SCIENTIFIC, INC.
Index
to Quarterly Report
on
Form 10-Q
Fiscal
Quarter Ended January 31, 2010
|
|||||
PAGE
|
|||||
3-4 | |||||
5 | |||||
6 | |||||
7-18 | |||||
19-31 | |||||
31 | |||||
31 | |||||
32 | |||||
32 | |||||
33 | |||||
34 | |||||
35 |
For
the Fiscal Quarters Ended January 31,
|
||||||||
In
thousands, except per share data
|
2010
|
2009
|
||||||
Revenue:
|
||||||||
Product
sales
|
$
|
94,794
|
$
|
88,752
|
||||
Service
sales
|
15,877
|
17,439
|
||||||
110,671
|
106,191
|
|||||||
Cost
of Sales:
|
||||||||
Cost
of products sold
|
67,618
|
63,674
|
||||||
Cost
of services sold
|
10,196
|
10,291
|
||||||
77,814
|
73,965
|
|||||||
Gross
profit
|
32,857
|
32,226
|
||||||
Selling,
general and administrative expenses
|
27,276
|
27,122
|
||||||
Research
and development
|
4,626
|
4,847
|
||||||
Restructuring
and other expenses
|
1,194
|
40
|
||||||
Operating
(loss) income
|
(239
|
)
|
217
|
|||||
Other
income (expense), net
|
(126
|
)
|
(2,470
|
)
|
||||
Interest
expense
|
(1,374
|
)
|
(654
|
)
|
||||
Loss
from continuing operations before income taxes
|
(1,739
|
)
|
(2,907
|
)
|
||||
Income
tax benefit
|
(981
|
)
|
(1,616
|
)
|
||||
Loss
from continuing operations, net of taxes
|
(758
|
)
|
(1,291
|
)
|
||||
Loss
from discontinued operations, net of taxes of $5 and $(25),
respectively
|
(51
|
)
|
(941
|
)
|
||||
Net
loss
|
$
|
(809
|
)
|
$
|
(2,232
|
)
|
||
Basic
loss per common share:
|
||||||||
Continuing
operations
|
$
|
(0.03
|
)
|
$
|
(0.05
|
)
|
||
Discontinued
operations
|
---
|
(0.04
|
)
|
|||||
Basic
loss per common share
|
$
|
(0.03
|
)
|
$
|
(0.09
|
)
|
||
Diluted
loss per common share:
|
||||||||
Continuing
operations
|
$
|
(0.03
|
)
|
$
|
(0.05
|
)
|
||
Discontinued
operations
|
---
|
(0.04
|
)
|
|||||
Diluted
loss per common share
|
$
|
(0.03
|
)
|
$
|
(0.09
|
)
|
||
Weighted
Average Common Shares Outstanding:
|
||||||||
Basic
|
25,195
|
24,131
|
||||||
Diluted
|
25,195
|
24,131
|
For
the Nine Months Ended January 31,
|
||||||||
In
thousands, except per share data
|
2010
|
2009
|
||||||
Revenue:
|
||||||||
Product
sales
|
$
|
292,104
|
$
|
341,702
|
||||
Service
sales
|
49,315
|
55,207
|
||||||
341,419
|
396,909
|
|||||||
Cost
of Sales:
|
||||||||
Cost
of products sold
|
211,048
|
247,298
|
||||||
Cost
of services sold
|
30,267
|
35,636
|
||||||
241,315
|
282,934
|
|||||||
Gross
profit
|
100,104
|
113,975
|
||||||
Selling,
general and administrative expenses
|
78,987
|
88,996
|
||||||
Research
and development
|
13,586
|
16,778
|
||||||
Restructuring
and other expenses
|
1,450
|
884
|
||||||
Operating
income
|
6,081
|
7,317
|
||||||
Other
income (expense), net
|
(1,525
|
)
|
(3,007
|
)
|
||||
Interest
expense
|
(3,234
|
)
|
(1,941
|
)
|
||||
Income
from continuing operations before income taxes
|
1,322
|
2,369
|
||||||
Income
tax benefit
|
(996
|
)
|
(3,429
|
)
|
||||
Income
from continuing operations, net of taxes
|
2,318
|
5,798
|
||||||
Loss
from discontinued operations, net of taxes of ($886) and $5,
respectively
|
(2,154
|
)
|
(1,255
|
)
|
||||
Net
income
|
$
|
164
|
$
|
4,543
|
||||
Basic
earnings (loss) per common share:
|
||||||||
Continuing
operations
|
$
|
0.09
|
$
|
0.24
|
||||
Discontinued
operations
|
(0.08
|
)
|
(0.05
|
)
|
||||
Basic
earnings per common share
|
$
|
0.01
|
$
|
0.19
|
||||
Diluted
earnings (loss) per common share:
|
||||||||
Continuing
operations
|
$
|
0.09
|
$
|
0.24
|
||||
Discontinued
operations
|
(0.08
|
)
|
(0.05
|
)
|
||||
Diluted
earnings per common share
|
$
|
0.01
|
$
|
0.19
|
||||
Weighted
Average Common Shares Outstanding:
|
||||||||
Basic
|
24,904
|
23,953
|
||||||
Diluted
|
24,936
|
24,064
|
January
31,
|
April
30,
|
|||||||
In
thousands
|
2010
|
2009
|
||||||
Assets:
|
||||||||
Current
Assets:
|
||||||||
Cash
and cash equivalents
|
$
|
7,921
|
$
|
10,313
|
||||
Accounts
receivable, net
|
72,744
|
87,798
|
||||||
Inventories
|
66,883
|
72,108
|
||||||
Deferred
tax assets, net
|
9,702
|
9,022
|
||||||
Prepaid
expenses and other current assets
|
5,717
|
4,659
|
||||||
Total
Current Assets
|
162,967
|
183,900
|
||||||
Property,
plant and equipment, net
|
33,423
|
37,119
|
||||||
Goodwill
|
83,027
|
76,940
|
||||||
Deferred
tax assets, net
|
45,640
|
43,339
|
||||||
Other
assets
|
21,416
|
17,919
|
||||||
Total
Assets
|
$
|
346,473
|
$
|
359,217
|
||||
Liabilities
and Shareholders' Equity:
|
||||||||
Current
Liabilities:
|
||||||||
Accounts
payable
|
$
|
38,566
|
$
|
37,494
|
||||
Accrued
compensation and benefits
|
12,717
|
15,735
|
||||||
Other
accrued liabilities
|
22,088
|
24,748
|
||||||
Deferred
revenue
|
12,329
|
13,084
|
||||||
Total
Current Liabilities
|
85,700
|
91,061
|
||||||
Long-term
debt
|
45,000
|
73,500
|
||||||
Accrued
pension benefit liability
|
30,366
|
29,629
|
||||||
Other
long-term liabilities
|
21,765
|
16,725
|
||||||
Commitments
and contingencies
|
||||||||
Shareholders'
Equity:
|
||||||||
Preferred
stock
|
---
|
---
|
||||||
Common
stock
|
257
|
252
|
||||||
Paid-in
capital
|
81,531
|
79,198
|
||||||
Retained
earnings
|
97,826
|
97,662
|
||||||
Treasury
stock
|
(11,035
|
)
|
(11,531
|
)
|
||||
Accumulated
other comprehensive loss
|
(4,937
|
)
|
(17,279
|
)
|
||||
Total
Shareholders' Equity
|
163,642
|
148,302
|
||||||
Total
Liabilities and Shareholders' Equity
|
$
|
346,473
|
$
|
359,217
|
For
the Nine Months Ended January 31,
|
||||||||
In
thousands
|
2010
|
2009
|
||||||
Cash
flows from operating activities:
|
||||||||
Net
income
|
$
|
164
|
$
|
4,543
|
||||
Adjustments
to reconcile net income to cash provided by
operating activities:
|
||||||||
Depreciation
and amortization
|
7,250
|
7,547
|
||||||
Deferred
income taxes
|
(2,430
|
)
|
(5,173
|
)
|
||||
Stock-based
compensation
|
2,914
|
2,428
|
||||||
Loss
(gain) on sale of assets
|
2,328
|
(622
|
)
|
|||||
Other-than-temporary
impairment charge
|
---
|
2,290
|
||||||
Other
noncash items
|
1,525
|
977
|
||||||
Changes
in operating accounts, excluding effects of acquisitions:
|
||||||||
Accounts
receivable
|
13,785
|
27,929
|
||||||
Inventories
|
(233
|
)
|
(3,166
|
)
|
||||
Prepaid
expenses and other assets
|
(775
|
)
|
(114
|
)
|
||||
Accounts
payable and other accrued liabilities
|
(1,717
|
)
|
(21,577
|
)
|
||||
Accrued
compensation and benefits
|
(3,333
|
)
|
(8,744
|
)
|
||||
Net
cash provided by operating activities
|
19,478
|
6,318
|
||||||
Cash
flows from investing activities:
|
||||||||
Capital
expenditures
|
(3,231
|
)
|
(6,471
|
)
|
||||
Proceeds
from sale of net assets
|
13,116
|
2,590
|
||||||
Proceeds
from sale of available for sale investments
|
149
|
705
|
||||||
Purchases
of available for sale investments
|
(113
|
)
|
(432
|
)
|
||||
Business
acquisitions
|
(3,473
|
)
|
(34,273
|
)
|
||||
Investments
in intangible assets
|
(1,149
|
)
|
(678
|
)
|
||||
Net
cash provided by (used for) investing activities
|
5,299
|
(38,559
|
)
|
|||||
Cash
flows from financing activities:
|
||||||||
Debt
repayments
|
(88,676
|
)
|
(56,771
|
)
|
||||
Debt
proceeds
|
61,104
|
88,500
|
||||||
Debt
issuance costs
|
(494
|
)
|
---
|
|||||
Common
stock activity
|
(190
|
)
|
899
|
|||||
Net
cash (used for) provided by financing activities
|
(28,256
|
)
|
32,628
|
|||||
Effect
of exchange rate changes on cash
|
1,087
|
(3,339
|
)
|
|||||
Decrease
in cash and cash equivalents
|
(2,392
|
)
|
(2,952
|
)
|
||||
Cash
and cash equivalents at beginning of period
|
10,313
|
13,892
|
||||||
Cash
and cash equivalents at end of period
|
$
|
7,921
|
$
|
10,940
|
January
31,
|
April
30,
|
|||||||
In
thousands
|
2010
|
2009
|
||||||
Raw
materials and purchased parts
|
$
|
55,657
|
$
|
58,779
|
||||
Work
in process
|
1,836
|
3,510
|
||||||
Finished
goods
|
9,390
|
9,819
|
||||||
Total
inventories
|
$
|
66,883
|
$
|
72,108
|
In
thousands
|
November
25, 2009
|
|||
Assets
acquired:
|
||||
Accounts
receivable
|
$ | 208 | ||
Prepaid
and other assets
|
12 | |||
Goodwill
|
3,531 | |||
Other
assets
|
2,797 | |||
Total
assets acquired
|
$ | 6,548 | ||
Liabilities
assumed:
|
||||
Accounts
payable
|
34 | |||
Other
accrued liabilities
|
158 | |||
Deferred
revenue
|
149 | |||
Other
long-term liabilities
|
1,021 | |||
Total
liabilities assumed
|
$ | 1,362 | ||
Net
assets acquired
|
$ | 5,186 | ||
Consideration:
|
||||
Cash
payment
|
$ | 2,012 | ||
Estimated
fair value of contingent consideration
|
3,174 | |||
Total
consideration
|
$ | 5,186 |
January
31, 2010
|
April
30, 2009
|
|||||||||||||||
In
thousands
|
Gross
Carrying
Amount
|
Accumulated
Amortization
|
Gross
Carrying
Amount
|
Accumulated
Amortization
|
||||||||||||
Amortized
intangible assets:
|
||||||||||||||||
Patents
|
$
|
8,337
|
$
|
3,607
|
$
|
7,603
|
$
|
3,210
|
||||||||
Other
|
8,067
|
1,080
|
5,131
|
739
|
||||||||||||
Total
amortized intangible assets
|
$
|
16,404
|
$
|
4,687
|
$
|
12,734
|
$
|
3,949
|
In
thousands
|
Sign
Making
and
Specialty
Graphics
|
Apparel
and
Flexible
Materials
|
Ophthalmic
Lens
Processing
|
Total
|
||||||||||||
Balance
as of April 30, 2009:
|
||||||||||||||||
Goodwill
|
$
|
118,690
|
$
|
34,207
|
$
|
38,696
|
$
|
191,593
|
||||||||
Accumulated
impairment losses
|
(92,953
|
)
|
---
|
(21,700
|
)
|
(114,653
|
)
|
|||||||||
Balance
as of April 30, 2009
|
25,737
|
34,207
|
16,996
|
76,940
|
||||||||||||
Business
acquisitions
|
1,086
|
3,897
|
---
|
4,983
|
||||||||||||
Business
dispositions
|
(972
|
)
|
(1,581
|
)
|
---
|
(2,553
|
)
|
|||||||||
Effects
of currency translation
|
1,615
|
2,042
|
--
|
3,657
|
||||||||||||
Balance
as of January 31, 2010
|
$
|
27,466
|
$
|
38,565
|
$
|
16,996
|
$
|
83,027
|
For
the Fiscal Quarters
Ended
January 31,
|
For
the Nine Months
Ended
January 31,
|
|||||||||||||||
In
thousands
|
2010
|
2009
|
2010
|
2009
|
||||||||||||
Sign
Making and Specialty Graphics:
|
||||||||||||||||
Gerber
Scientific Products
|
$
|
9,341
|
$
|
11,938
|
$
|
33,603
|
$
|
45,457
|
||||||||
Spandex
|
50,267
|
45,430
|
159,094
|
177,122
|
||||||||||||
Sign
Making and Specialty Graphics
|
59,608
|
57,368
|
192,697
|
222,579
|
||||||||||||
Apparel
and Flexible Materials
|
40,095
|
36,437
|
112,249
|
130,768
|
||||||||||||
Ophthalmic
Lens Processing
|
10,968
|
12,386
|
36,473
|
43,562
|
||||||||||||
Consolidated
revenue
|
$
|
110,671
|
$
|
106,191
|
$
|
341,419
|
$
|
396,909
|
||||||||
Sign
Making and Specialty Graphics:
|
||||||||||||||||
Gerber
Scientific Products
|
$
|
(2,488
|
)
|
$
|
334
|
$
|
(4,950
|
)
|
$
|
(881
|
)
|
|||||
Spandex
|
2,730
|
704
|
9,255
|
6,832
|
||||||||||||
Sign
Making and Specialty Graphics
|
242
|
1,038
|
4,305
|
5,951
|
||||||||||||
Apparel
and Flexible Materials
|
4,140
|
2,778
|
11,597
|
11,373
|
||||||||||||
Ophthalmic
Lens Processing
|
(318
|
)
|
737
|
2,002
|
2,625
|
|||||||||||
Segment
operating income
|
4,064
|
4,553
|
17,904
|
19,949
|
||||||||||||
Corporate
operating expenses
|
(4,303
|
)
|
(4,336
|
)
|
(11,823
|
)
|
(12,632
|
)
|
||||||||
Consolidated
operating (loss) income
|
$
|
(239
|
)
|
$
|
217
|
$
|
6,081
|
$
|
7,317
|
For
the Fiscal Quarters
Ended
January 31,
|
For
the Nine Months
Ended
January 31,
|
|||||||||||||||
In
thousands
|
2010
|
2009
|
2010
|
2009
|
||||||||||||
Net
(loss) income
|
$
|
(809
|
)
|
$
|
(2,232
|
)
|
$
|
164
|
$
|
4,543
|
||||||
Other
comprehensive (loss) income:
|
||||||||||||||||
Foreign
currency translation adjustments
|
(3,765
|
)
|
(3,677
|
)
|
11,346
|
(31,266
|
)
|
|||||||||
Defined
benefit pension plans activity, net of tax
|
96
|
205
|
288
|
614
|
||||||||||||
Unrealized
investment gain income, net of tax
|
79
|
1,283
|
450
|
474
|
||||||||||||
Net
gain (loss) on derivative instruments, net of tax
|
142
|
(561
|
)
|
258
|
(688
|
)
|
||||||||||
Total
comprehensive (loss) income
|
$
|
(4,257
|
)
|
$
|
(4,982
|
)
|
$
|
12,506
|
$
|
(26,323
|
)
|
For
the Fiscal Quarters Ended January 31,
|
||||||||||||||||||||||||
2010
|
2009
|
|||||||||||||||||||||||
In
thousands, except per share amounts
|
Net
Loss
|
Average
Shares
|
Per
Share
|
Net
Loss
|
Average
Shares
|
Per
Share
|
||||||||||||||||||
Basic
loss per common share:
|
||||||||||||||||||||||||
Continuing
operations
|
$
|
(758
|
)
|
25,195
|
$
|
(0.03
|
)
|
$
|
(1,291
|
)
|
24,131
|
$
|
(0.05
|
)
|
||||||||||
Discontinued
operations
|
$
|
(51
|
)
|
25,195
|
---
|
(941
|
)
|
24,131
|
(0.04
|
)
|
||||||||||||||
Basic
loss per common share
|
$
|
(809
|
)
|
25,195
|
$
|
(0.03
|
)
|
$
|
(2,232
|
)
|
24,131
|
$
|
(0.09
|
)
|
||||||||||
Diluted loss per common
share:
|
||||||||||||||||||||||||
Continuing
operations
|
$
|
(758
|
)
|
25,195
|
$
|
(0.03
|
)
|
$
|
(1,291
|
)
|
24,131
|
$
|
(0.05
|
)
|
||||||||||
Effect
of dilutive options and awards
|
---
|
---
|
---
|
---
|
---
|
---
|
||||||||||||||||||
Continuing
operations
|
$
|
(758
|
)
|
25,195
|
$
|
(0.03
|
)
|
$
|
(1,291
|
)
|
24,131
|
$
|
(0.05
|
)
|
||||||||||
Discontinued
operations
|
$
|
(51
|
)
|
25,195
|
---
|
(941
|
)
|
24,131
|
(0.04
|
)
|
||||||||||||||
Diluted
loss per common share
|
$
|
(809
|
)
|
25,195
|
$
|
(0.03
|
)
|
$
|
(2,232
|
)
|
24,131
|
$
|
(0.09
|
)
|
For
the Nine Months Ended January 31,
|
||||||||||||||||||||||||
2010
|
2009
|
|||||||||||||||||||||||
In
thousands, except per share amounts
|
Net
Income
|
Average
Shares
|
Per
Share
|
Net
Income
|
Average
Shares
|
Per
Share
|
||||||||||||||||||
Basic
earnings (loss) per common share:
|
||||||||||||||||||||||||
Continuing
operations
|
$
|
2,318
|
24,904
|
$
|
0.09
|
$
|
5,798
|
23,953
|
$
|
0.24
|
||||||||||||||
Discontinued
operations
|
$
|
(2,154
|
)
|
24,904
|
$
|
(0.08
|
)
|
(1,255
|
)
|
23,953
|
(0.05
|
)
|
||||||||||||
Basic
earnings per common share
|
$
|
164
|
24,904
|
$
|
0.01
|
$
|
4,543
|
23,953
|
$
|
0.19
|
||||||||||||||
Diluted earnings (loss) per common
share:
|
||||||||||||||||||||||||
Continuing
operations
|
$
|
2,318
|
24,904
|
$
|
0.09
|
$
|
5,798
|
23,953
|
$
|
0.24
|
||||||||||||||
Effect
of dilutive options and awards
|
---
|
32
|
---
|
---
|
111
|
---
|
||||||||||||||||||
Continuing
operations
|
$
|
2,318
|
24,936
|
$
|
0.09
|
$
|
5,798
|
24,064
|
$
|
0.24
|
||||||||||||||
Discontinued
operations
|
$
|
(2,154
|
)
|
24,936
|
$
|
(0.08
|
)
|
(1,255
|
)
|
24,064
|
(0.05
|
)
|
||||||||||||
Diluted
earnings per common share
|
$
|
164
|
24,936
|
$
|
0.01
|
$
|
4,543
|
24,064
|
$
|
0.19
|
For
the Nine Months Ended January 31,
|
||||||||
In
thousands
|
2010
|
2009
|
||||||
Beginning
balance
|
$
|
2,815
|
$
|
2,327
|
||||
Warranties
issued in the current period
|
4,342
|
3,738
|
||||||
Reductions
for costs incurred
|
(4,128
|
)
|
(3,984
|
)
|
||||
Impact
of business acquisitions
|
---
|
668
|
||||||
Impact
of business dispositions
|
(574
|
)
|
---
|
|||||
Ending
balance
|
$
|
2,455
|
$
|
2,749
|
For
the Fiscal Quarters
Ended
January 31,
|
For
the Nine Months
Ended
January 31,
|
|||||||||||||||
In
thousands
|
2010
|
2009
|
2010
|
2009
|
||||||||||||
Service
cost
|
$
|
---
|
$
|
597
|
$
|
---
|
$
|
1,791
|
||||||||
Interest
cost
|
1,698
|
1,770
|
5,096
|
5,310
|
||||||||||||
Expected
return on plan assets
|
(1,316
|
)
|
(1,709
|
)
|
(3,948
|
)
|
(5,129
|
)
|
||||||||
Amortization
of:
|
||||||||||||||||
Prior
service cost
|
---
|
73
|
---
|
219
|
||||||||||||
Actuarial
loss
|
153
|
253
|
459
|
759
|
||||||||||||
Net
periodic benefit cost
|
$
|
535
|
$
|
984
|
$
|
1,607
|
$
|
2,950
|
In
thousands
|
Balance
Sheet Location
|
January
31,
2010
|
April
30,
2009
|
||||||
Derivatives
designated as hedging instruments:
|
|||||||||
Interest
rate swap arrangements
|
Other
accrued liabilities
|
$ | 770 | $ | 1,181 |
In
thousands
|
For
the Fiscal Quarter
Ended January
31, 2010
|
For
the Nine Months
Ended
January 31, 2010
|
||||||
Loss
recognized in Accumulated Other Comprehensive Loss before tax
effect
|
$ | 71 | $ | 404 | ||||
Loss
reclassified from Accumulated Other Comprehensive Loss to Interest Expense
(effective portion)
|
$ | 297 | $ | 815 |
In
thousands
|
Total
|
Quoted
prices
in
active
markets
(Level
1)
|
Significant
other
observable
inputs
(Level
2)
|
Significant
unobservable
inputs
(Level
3)
|
||||||||||||
Available
for sale investments
|
$
|
3,708
|
$
|
3,708
|
$
|
---
|
$
|
---
|
||||||||
Interest
rate swap agreements
|
(770
|
)
|
---
|
(770
|
)
|
---
|
||||||||||
Estimated
fair value of contingent consideration
|
(3,174
|
)
|
---
|
---
|
(3,174
|
)
|
||||||||||
Total
|
$
|
(236
|
)
|
$
|
3,708
|
$
|
(770
|
)
|
$
|
(3,174
|
)
|
For
the Fiscal Quarters Ended
January
31,
|
For
the Nine Months Ended
January
31,
|
|||||||||||||||
In
thousands
|
2010
|
2009
|
2010
|
2009
|
||||||||||||
Revenue
from discontinued operations
|
$
|
---
|
$
|
6,572
|
$
|
5,973
|
$
|
7,122
|
||||||||
Pretax
(loss) income from discontinued operations
|
$
|
(181
|
)
|
$
|
(318
|
)
|
$
|
618
|
$
|
(131
|
)
|
In
thousands
|
September
1, 2009
|
|||
Assets:
|
||||
Accounts
receivable, net
|
$ | 3,069 | ||
Inventories
|
3,848 | |||
Prepaid
and other assets
|
66 | |||
Total current
assets
|
6,983 | |||
Property,
plant and equipment, net
|
1,336 | |||
Total
assets
|
$ | 8,319 | ||
Liabilities:
|
||||
Accounts
payable
|
$ | 1,142 | ||
Accrued
compensation and benefits
|
488 | |||
Other
accrued liabilities
|
1,577 | |||
Other
liabilities
|
229 | |||
Total
liabilities
|
$ | 3,436 | ||
Net
assets
|
$ | 4,883 |
For
the Fiscal Quarters Ended
January
31,
|
For
the Nine Months Ended
January
31,
|
|||||||||||||||
In
thousands
|
2010
|
2009
|
2010
|
2009
|
||||||||||||
Revenue
from discontinued operations
|
$
|
---
|
$
|
6,574
|
$
|
13,901
|
$
|
25,272
|
||||||||
Pretax
income (loss) from discontinued operations
|
$
|
21
|
$
|
(73
|
)
|
$
|
(3,392
|
)
|
$
|
33
|
In
thousands
|
September
30, 2009
|
|||
Assets:
|
||||
Accounts
receivable, net
|
$ | 4,413 | ||
Inventories
|
4,579 | |||
Prepaid
and other assets
|
174 | |||
Total current
assets
|
9,166 | |||
Property,
plant and equipment, net
|
720 | |||
Other
long-term assets
|
60 | |||
Total
assets
|
$ | 9,946 | ||
Liabilities:
|
||||
Accounts
payable
|
$ | 1,332 | ||
Accrued
compensation and benefits
|
130 | |||
Other
accrued liabilities
|
146 | |||
Total
liabilities
|
$ | 1,608 | ||
Net
assets
|
$ | 8,338 |
For
the Fiscal Quarters Ended
January
31,
|
For
the Nine Months Ended
January31,
|
|||||||||||||||
In
thousands
|
2010
|
2009
|
2010
|
2009
|
||||||||||||
Revenue
from discontinued operations
|
$
|
---
|
$
|
760
|
$
|
1,234
|
$
|
3,410
|
||||||||
Pretax
income (loss) from discontinued operations
|
$
|
114
|
$
|
(575
|
)
|
$
|
(266
|
)
|
$
|
(1,152
|
)
|
Twelve
Month Period Ended
|
Previous
Covenant
|
Amended
Covenant
|
January
31, 2010
|
Maximum
3.25:1
|
Maximum
3.00:1
|
April
30, 2010
|
Maximum
3.25:1
|
Maximum
3.00:1
|
July
31, 2010 and thereafter
|
Maximum
3.00:1
|
Maximum
3.00:1
|
Twelve
Month Period Ended
|
Previous
Covenant
|
Amended
Covenant
|
January
31, 2010
|
Minimum
2.25:1
|
Minimum
1.50:1
|
April
30, 2010
|
Minimum
2.75:1
|
Minimum
2.25:1
|
July
31, 2010
|
Minimum
3.00:1
|
Minimum
2.50:1
|
October
31, 2010 and thereafter
|
Minimum
3.00:1
|
Minimum
3.00:1
|
·
|
expected
financial condition, future earnings, levels of growth, or other measures
of financial performance, or the future size of market segments or
geographic markets;
|
·
|
economic
conditions;
|
·
|
planned
cost reductions;
|
·
|
future
cash flows and uses of cash and debt reduction
strategies;
|
·
|
prospective
product developments and business growth opportunities, as well as
competitor product developments;
|
·
|
demand
for Gerber's products and services;
|
·
|
methods
of and costs associated with potential geographic
expansion;
|
·
|
regulatory
and market developments and the impact of such developments on future
operating results;
|
·
|
potential
impacts from credit market risk;
|
·
|
future
effective income tax rates;
|
·
|
the
outcome of contingencies;
|
·
|
the
availability and cost of raw materials;
and
|
·
|
pension
plan assumptions and future
contributions.
|
For
the Fiscal Quarters Ended
January
31,
|
For
the Nine Months Ended
January
31,
|
|||||||||||||||||||||||
In
thousands
|
2010
|
2009
|
Percent
Change
|
2010
|
2009
|
Percent
Change
|
||||||||||||||||||
Equipment
and software
|
$
|
30,523
|
$
|
30,501
|
0.1
|
%
|
$
|
86,252
|
$
|
115,484
|
(25.3
|
%)
|
||||||||||||
Aftermarket
supplies
|
64,271
|
58,251
|
10.3
|
%
|
205,852
|
226,218
|
(9.0
|
%)
|
||||||||||||||||
Service
|
15,877
|
17,439
|
(9.0
|
%)
|
49,315
|
55,207
|
(10.7
|
%)
|
||||||||||||||||
Total
revenue
|
$
|
110,671
|
$
|
106,191
|
4.2
|
%
|
$
|
341,419
|
$
|
396,909
|
(14.0
|
%)
|
In
thousands
|
January
31,
2010
|
April
30,
2009
|
||||||
Backlog:
|
||||||||
Sign
Making and Specialty Graphics
|
$
|
825
|
$
|
1,636
|
||||
Apparel
and Flexible Materials
|
24,526
|
21,800
|
||||||
Ophthalmic
Lens Processing
|
662
|
1,200
|
||||||
$
|
26,013
|
$
|
24,636
|
For
the Fiscal Quarters Ended
January
31,
|
For
the Nine Months Ended
January
31,
|
|
|||||||||||||||
In
thousands
|
2010
|
2009
|
Percent
Change
|
2010
|
2009
|
Percent
Change
|
|||||||||||
Gross
profit
|
$
|
32,857
|
$
|
32,226
|
2.0
|
%
|
$
|
100,104
|
$
|
113,975
|
(12.2
|
%)
|
|||||
Gross
profit margin
|
29.7
|
%
|
30.3
|
%
|
29.3
|
%
|
28.7
|
%
|
For
the Fiscal Quarters Ended
January
31,
|
For
the Nine Months Ended
January
31,
|
|
|||||||||||||||
In
thousands
|
2010
|
2009
|
Percent
Change
|
2010
|
2009
|
Percent
Change
|
|||||||||||
Selling,
general and administrative expenses
|
$
|
27,276
|
$
|
27,122
|
0.6
|
%
|
$
|
78,987
|
$
|
88,996
|
(11.2
|
%)
|
|||||
Percentage
of revenue
|
24.6
|
%
|
25.5
|
%
|
23.1
|
%
|
22.4
|
%
|
For
the Fiscal Quarters Ended
January
31,
|
For
the Nine Months Ended
January
31,
|
|
||||||||||||||||||||||
In
thousands
|
2010
|
2009
|
Percent
Change
|
2010
|
2009
|
Percent
Change
|
||||||||||||||||||
Research
and development
|
$
|
4,626
|
$
|
4,847
|
(4.6
|
%)
|
$
|
13,586
|
$
|
16,778
|
(19.0
|
%)
|
||||||||||||
Percentage
of revenue
|
4.2
|
%
|
4.6
|
%
|
4.0
|
%
|
4.2
|
%
|
For
the Fiscal Quarters Ended
January
31,
|
For
the Nine Months Ended
January
31,
|
|||||||||||||||
In
thousands
|
2010
|
2009
|
2010
|
2009
|
||||||||||||
Restructuring
and other expenses
|
$
|
1,194
|
$
|
40
|
$
|
1,450
|
$
|
884
|
For
the Fiscal Quarters Ended
January
31,
|
For
the Nine Months Ended
January
31,
|
|||||||||||||||
In
thousands
|
2010
|
2009
|
2010
|
2009
|
||||||||||||
Other
income (expense), net
|
$
|
(126
|
)
|
$
|
(2,470
|
)
|
$
|
(1,525
|
)
|
$
|
(3,007
|
)
|
For
the Fiscal Quarters Ended
January
31,
|
For
the Nine Months Ended
January
31,
|
|||||||||||||||||||||||
In
thousands
|
2010
|
2009
|
Percent
Change
|
2010
|
2009
|
Percent
Change
|
||||||||||||||||||
Interest
expense
|
$
|
1,374
|
$
|
654
|
110.1
|
%
|
$
|
3,234
|
$
|
1,941
|
66.6
|
%
|
||||||||||||
Weighted-average
credit facility interest rate
|
8.1
|
%
|
4.6
|
%
|
7.3
|
%
|
5.1
|
%
|
For
the Fiscal Quarters Ended
January
31,
|
For
the Nine Months Ended
January
31,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Effective
tax rate
|
(56.4
|
%)
|
(55.6
|
%)
|
(75.3
|
%)
|
(144.7
|
%)
|
Operating
Segment
|
Principal
Business
|
Sign
Making and Specialty Graphics
|
Gerber
Scientific Products ("GSP") and Spandex
|
Apparel
and Flexible Materials
|
Gerber
Technology
|
Ophthalmic
Lens Processing
|
Gerber
Coburn
|
For
the Fiscal Quarters Ended January 31,
|
||||||||||||||||||||||||
2010
|
2009
|
|||||||||||||||||||||||
In
thousands
|
GSP
|
Spandex
|
Total
|
GSP
|
Spandex
|
Total
|
||||||||||||||||||
Revenue
|
$
|
9,341
|
$
|
50,267
|
$
|
59,608
|
$
|
11,938
|
$
|
45,430
|
$
|
57,368
|
||||||||||||
Operating
(loss) income
|
$
|
(2,488
|
)
|
$
|
2,730
|
$
|
242
|
$
|
334
|
$
|
704
|
$
|
1,038
|
For
the Nine Months Ended January 31,
|
||||||||||||||||||||||||
2010
|
2009
|
|||||||||||||||||||||||
In
thousands
|
GSP
|
Spandex
|
Total
|
GSP
|
Spandex
|
Total
|
||||||||||||||||||
Revenue
|
$
|
33,603
|
$
|
159,094
|
$
|
192,697
|
$
|
45,457
|
$
|
177,122
|
$
|
222,579
|
||||||||||||
Operating
(loss) income
|
$
|
(4,950
|
)
|
$
|
9,255
|
$
|
4,305
|
$
|
(881
|
)
|
$
|
6,832
|
$
|
5,951
|
For
the Fiscal Quarters Ended
January
31,
|
For
the Nine Months Ended
January
31,
|
|||||||||||||||
In
thousands
|
2010
|
2009
|
2010
|
2009
|
||||||||||||
Revenue
|
$
|
40,095
|
$
|
36,437
|
$
|
112,249
|
$
|
130,768
|
||||||||
Segment
operating income
|
$
|
4,140
|
$
|
2,778
|
$
|
11,597
|
$
|
11,373
|
For
the Fiscal Quarters Ended
January
31,
|
For
the Nine Months Ended
January
31,
|
|||||||||||||||
In
thousands
|
2010
|
2009
|
2010
|
2009
|
||||||||||||
Revenue
|
$
|
10,968
|
$
|
12,386
|
$
|
36,473
|
$
|
43,562
|
||||||||
Segment
operating (loss) income
|
$
|
(318
|
)
|
$
|
737
|
$
|
2,002
|
$
|
2,625
|
For
the Fiscal Quarters Ended
January
31,
|
For
the Nine Months Ended
January
31,
|
|||||||||||||||
In
thousands
|
2010
|
2009
|
2010
|
2009
|
||||||||||||
Operating
expenses
|
$
|
4,303
|
$
|
4,336
|
$
|
11,823
|
$
|
12,632
|
In
thousands, except ratio amounts
|
January
31,
2010
|
April
30,
2009
|
||||||
Cash
and cash equivalents
|
$
|
7,921
|
$
|
10,313
|
||||
Working
capital
|
$
|
77,267
|
$
|
92,839
|
||||
Total
debt
|
$
|
45,000
|
$
|
73,500
|
||||
Net
debt (total debt less cash and cash equivalents)
|
$
|
37,079
|
$
|
63,187
|
||||
Shareholders'
equity
|
$
|
163,642
|
$
|
148,302
|
||||
Total
capital (net debt plus shareholders' equity)
|
$
|
200,721
|
$
|
211,489
|
||||
Current
ratio
|
1.90:1
|
2.02:1
|
||||||
Net
debt-to-total capital ratio
|
18.5
|
%
|
29.9
|
%
|
For
the Nine Months Ended January 31,
|
||||||||
In
thousands
|
2010
|
2009
|
||||||
Cash
flows provided by operating activities
|
$
|
19,478
|
$
|
6,318
|
||||
Cash
flows provided by (used for) investing activities
|
$
|
5,299
|
$
|
(38,559
|
)
|
|||
Cash
flows (used for) provided by financing activities
|
$
|
(28,256
|
)
|
$
|
32,628
|
Twelve
Month Period Ended
|
Previous
Covenant
|
Amended
Covenant
|
January
31, 2010
|
Maximum
3.25:1
|
Maximum
3.00:1
|
April
30, 2010
|
Maximum
3.25:1
|
Maximum
3.00:1
|
July
31, 2010 and thereafter
|
Maximum
3.00:1
|
Maximum
3.00:1
|
Twelve
Month Period Ended
|
Previous
Covenant
|
Amended
Covenant
|
January
31, 2010
|
Minimum
2.25:1
|
Minimum
1.50:1
|
April
30, 2010
|
Minimum
2.75:1
|
Minimum
2.25:1
|
July
31, 2010
|
Minimum
3.00:1
|
Minimum
2.50:1
|
October
31, 2010 and thereafter
|
Minimum
3.00:1
|
Minimum
3.00:1
|
Covenant
|
Requirement
|
Actual
as of January 31, 2010
|
Total
Funded Debt to Consolidated EBITDA
|
Maximum
3.00:1
|
2.36:1
|
Consolidated
EBIT to Consolidated Interest Expense
|
Minimum
1.50:1
|
2.66:1
|
Asset
Coverage Ratio
|
At
least 1.0:1
|
1.52:1
|
Period
|
(a)
Total
Number
of
Shares
(or
Units)
Purchased
|
(b)
Average
Price
Paid
per
Share
(or
Unit)
|
(c)
Total
Number of
Shares
(or Units)
Purchased
as Part
of
Publicly
Announced
Plans
or
Programs
|
(d)
Maximum
Number
(or
Approximate
Dollar
Value)
of
Shares (or Units)
that
May Yet Be
Purchased
Under the
Plans
or Program
|
||||||
November
1, 2009 – November 30, 2009
|
---
|
---
|
Not
applicable
|
Not
applicable
|
||||||
December
1, 2009 – December 31, 2009 (1)
|
14,129
|
$
|
5.04
|
Not
applicable
|
Not
applicable
|
|||||
January
1, 2010 – January 31, 2010 (1)
|
2,072
|
4.94
|
Not
applicable
|
Not
applicable
|
||||||
16,201
|
$
|
5.02
|
Not
applicable
|
Not
applicable
|
Exhibit
Number
|
Description
|
||
10.1
|
Third
Amendment to Credit Agreement, dated as of November 19, 2009, among Gerber
Scientific, Inc., certain subsidiaries of Gerber Scientific, Inc., JP
Morgan Chase Bank N.A., HSBC Bank USA, National Association, Merrill Lynch
Capital Corporation, Bank of America, N.A., Sovereign Bank, and RBS
Citizens N.A. as lender and agent. Filed
herewith.
|
||
31.1
|
Certification
of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)
under the Securities Exchange Act of 1934, filed
herewith.
|
||
31.2
|
Certification
of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)
under the Securities Exchange Act of 1934, filed
herewith.
|
||
32
|
Certification
of Chief Executive Officer and Chief Financial Officer pursuant to Rule
13a-14(b) or 15d-14(b) under the Securities Exchange Act of 1934 and to 18
U.S.C. 1350, filed herewith.
|
GERBER
SCIENTIFIC, INC.
|
||
March
8, 2010
|
By:
|
/s/ Michael R.
Elia
|
Michael R.
Elia
Executive
Vice President, Chief Financial Officer and Chief Accounting
Officer
(Principal
Financial and Accounting
Officer)
|
Exhibit
Number
|
Description
|
||
Third
Amendment to Credit Agreement, dated as of November 19, 2009, among Gerber
Scientific, Inc., certain subsidiaries of Gerber Scientific, Inc., JP
Morgan Chase Bank N.A., HSBC Bank USA, National Association, Merrill Lynch
Capital Corporation, Bank of America, N.A., Sovereign Bank, and RBS
Citizens N.A. as lender and agent. Filed
herewith.
|
|||
Certification
of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)
under the Securities Exchange Act of 1934, filed
herewith.
|
|||
Certification
of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)
under the Securities Exchange Act of 1934, filed
herewith.
|
|||
Certification
of Chief Executive Officer and Chief Financial Officer pursuant to Rule
13a-14(b) or 15d-14(b) under the Securities Exchange Act of 1934 and to 18
U.S.C. 1350, filed herewith.
|